The patient denies cancer diagnosis, he informed that at 2013, the physician prescribed Nolvadex due the PSA 4ng/ml, after Noldavex use on 2015, he experienced PSA 0,4ng/ML.
Due the adverse events, the patient discontinued the treatment on 2015 by himself. On Aug-2017, he returns the treatment and this moment he experiencing erectile dysfunction and diarrhea. He does not know the current value of PSA.
Due the adverse events, the patient discontinued the treatment on 2015 by himself. On Aug-2017, he returns the treatment and this moment he experiencing erectile dysfunction and diarrhea. He does not know the current value of PSA.